Principia Biopharma

Company Description

Principia is a clinical-stage biopharmaceutical company dedicated to bringing transformative oral therapies to patients with significant unmet medical needs in immunology and oncology. The Company’s proprietary Tailored Covalency® platform enables it to design and develop reversible and irreversible covalent, small molecule inhibitors with potencies and selectivities that have the potential to rival those of injectable biologics, yet maintain the convenience of a pill.

Company Overview

NamePrincipia Biopharma
SectorPharma

IPO Data

Date14.09.2018
Price$ 17
Offer Share650.000
Deal Size$ 100.000.000
Company SymbolPRNB
Stock MarketNASDAQ (NASDAQ)
Popular Investor - EN
E-NEWSLETTER SUBSCRIPTION
Subscribe to our e-mail list to be notified of updates and recent announcements on our website.
FOLLOW US
Don't forget to follow us on social media